Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Gemin4. A novel component of the SMN complex that is found in both gems and nucleoli.
Charroux B
,
Pellizzoni L
,
Perkinson RA
,
Yong J
,
Shevchenko A
,
Mann M
,
Dreyfuss G
.
???displayArticle.abstract???
The survival of motor neurons (SMN) protein, the product of the neurodegenerative disease spinal muscular atrophy (SMA) gene, is localized both in the cytoplasm and in discrete nuclear bodies called gems. In both compartments SMN is part of a large complex that contains several proteins including Gemin2 (formerly SIP1) and the DEAD box protein Gemin3. In the cytoplasm, the SMN complex is associated with snRNP Sm core proteins and plays a critical role in spliceosomal snRNP assembly. In the nucleus, SMN is required for pre-mRNA splicing by serving in the regeneration of spliceosomes. These functions are likely impaired in cells of SMA patients because they have reduced levels of functional SMN. Here, we report the identification by nanoelectrospray mass spectrometry of a novel component of the SMN complex that we name Gemin4. Gemin4 is associated in vivo with the SMN complex through a direct interaction with Gemin3. The tight interaction of Gemin4 with Gemin3 suggests that it could serve as a cofactor of this DEAD box protein. Gemin4 also interacts directly with several of the Sm core proteins. Monoclonal antibodies against Gemin4 efficiently immunoprecipitate the spliceosomal U snRNAs U1 and U5 from Xenopus oocytes cytoplasm. Immunolocalization experiments show that Gemin4 is colocalized with SMN in the cytoplasm and in gems. Interestingly, Gemin4 is also detected in the nucleoli, suggesting that the SMN complex may also function in preribosomal RNA processing or ribosome assembly.
Figure 1. Immunoprecipitation of the SMN complex with mAb against SMN. Immunoprecipitations using anti-SMN mAb 2B1 and [35S]methionine-labeled HeLa cell cytoplasmic extract. The immunoprecipitated proteins were analyzed by SDS-PAGE and autoradiography. Antibody 2B1 (lane 2B1) immunoprecipitates SMN, Gemin2, Gemin3, Sm proteins B, Bâ², D1-3, E, F, and G, and a group of proteins indicated as p175, p97, p95, p60, and p50. The SP2/0 lane shows the background of immunoprecipitation (lane SP2/0). The position of the molecular mass markers is indicated on the left in kilodaltons.
Figure 2. mAb 22C10 is specific for Gemin4. (A) Myc-tagged Gemin4, hnRNP A1, and SMN proteins were produced in rabbit reticulocyte lysate in the presence of [35S]methionine. The labeled proteins were immunoprecipitated using mAb 22C10, and the immunoprecipitated material was analyzed by SDS-PAGE and autoradiography. The left panel shows 10% of the in vitro translated proteins. (B) Immunoblotting using mAb 22C10 on total HeLa extract. (C) Immunoprecipitations using anti-Gemin4 mAb 22C10 and [35S]methionine-labeled HeLa or mouse 3T3 cell extracts. The immunoprecipitated proteins were analyzed by SDS-PAGE and autoradiography. The position of the molecular mass markers is indicated on the left in kilodaltons.
Figure 3. The Gemin4 protein colocalizes with SMN in gems and is detected in nucleoli. (A) Laser confocal image of indirect immunofluorescence on HeLa cells using mAb 22C10 against the Gemin4 protein, arrows in A indicate gems. (B and C) Superimposed laser confocal images of double label immunofluorescence microscopy experiments using antibodies against p80 coilin (B and C, red), SMN (B, green), and Gemin4 (C, green). (D) Differential interference contrast image of the same cell shown in C, arrows indicate gems and arrowheads indicate CBs. (E) Superimposed laser confocal images of double label immunofluorescence microscopy experiments using mAb against Gemin4 (green) and a rabbit affinity-purified antibody against exon 7 epitope of the human SMN protein (red). (F) Superimposed laser confocal images of double label immunofluorescence microscopy experiments using mAbs against Gemin4 (green) and against fibrillarin (red). Dashed lines demarcate the nucleus. A is a z-series composite stack of confocal sections that shows the cytoplasmic staining of Gemin4. B, C, E, and F, are confocal sections through the nucleus that underestimate the cytoplasmic staining of Gemin4 and/or SMN.
Figure 4. Gemin4 is in a complex with SMN, Gemin2, and Gemin3. (A and B) SMN, Gemin2, Gemin3, and Gemin4 can be coimmunoprecipitated in vivo. (A) mAbs against Gemin4 coimmunoprecipitate SMN, Gemin2, and Gemin3. Immunoprecipitation from total the HeLa extract was done with mAb anti-Gemin4 (22C10) and the immunoprecipitated proteins were analyzed by Western blot using 2B1 (anti-SMN), 2S7 (anti-Gemin2), or 11G9 (anti-Gemin3) antibodies. (B) mAbs against SMN, Gemin2, and Gemin3 coimmunoprecipitate Gemin4. Immunoprecipitation from total HeLa extract was done with mAb anti-SMN (lane 2B1 IP), anti-Gemin2 (lane 2S7 IP), anti-Gemin3 (lane 11G9 IP), or SP2/O (lane SP2/O IP) as a negative control. The immunoprecipitated proteins were analyzed by Western blot using the anti-Gemin4 mAb 22C10. The position of the molecular mass markers is indicated on the left (in kD) and the positions of the light chain (l.c) and heavy chain (h.c) of the antibodies used for immunoprecipitation are indicated. (C) Gel filtration analysis of SMN complexes. Total HeLa extract was fractionated on a Superose 6 HR 10/30 column. The fractions were analyzed by SDS-PAGE, and SMN, Gemin2, Gemin3, and Gemin4 proteins were detected by Western blotting. The fraction number and the molecular mass standards are indicated.
Figure 5. Gemin4 interacts directly with the DEAD box protein Gemin3 in vitro. (A) Gemin4 interacts with Gemin3 in vitro. In vitro translated [35S]methionine-labeled myc-tagged SMN, Gemin2, Gemin3, and Gemin4 proteins were incubated with purified GST-Gemin4 as described in Materials and Methods. Bound proteins were analyzed by SDS-PAGE and fluorography. The in vitro translation panel shows 5% of the input. The position of the molecular mass markers is indicated on the left in kilodaltons. (B) Gemin4 interacts tightly with Gemin3. In vitro translated [35S]methionine-labeled myc-Gemin4 was incubated with purified GST-Gemin3 in increasing salt concentrations as indicated (see Materials and Methods). Bound proteins were analyzed by SDS-PAGE and fluorography. The in vitro translation panel shows 10% of the input.
Figure 6. Gemin4 is associated with snRNPs in vivo. (A) Immunoprecipitations of [35S]methionine-labeled total HeLa cell extract using mAbs specific to SMN (2B1), Gemin4 (22C10), and the snRNP Sm core proteins (Y12). The immunoprecipitated proteins were analyzed by SDS-PAGE and autoradiography. The several proteins immunoprecipitated are indicated on the right. (B) Gemin4 is coimmunoprecipitated with Sm proteins. Immunoprecipitation from the total HeLa extract was performed with mAb anti-Sm (Y12) and the immunoprecipitated proteins were analyzed by Western blotting using 22C10 (anti-Gemin4). The position of the molecular mass markers is indicated on the left (in kD). The positions of the light chain (l.c) and heavy chain (h.c) of the antibody used for immunoprecipitation are indicated. The total lane shows 2% of the input. (C) Gemin4 interacts with several Sm proteins in vitro. In vitro translated [35S]methionine-labeled myc-tagged Sm proteins B, D1, D2, D3, E, F, and G were incubated with purified GST-Gemin4 as described in Materials and Methods. Bound proteins were analyzed by SDS-PAGE and fluorography. The in vitro translation panel shows 5% of the input. The position of the molecular mass markers is indicated on the left in kilodaltons. (D) Gemin4 interacts directly with SmB in vitro. Recombinant His-tagged SmB protein was incubated with purified GST or GST-Gemin4 proteins as described in Materials and Methods. Bound proteins were analyzed by SDS-PAGE and Western blotting with an anti-His tag antibodies.
Figure 7. Gemin4 is associated with spliceosomal U snRNAs in the cytoplasm of Xenopus oocytes. (A) Immunoprecipitation of spliceosomal U snRNAs with anti-Gemin2 and anti-Gemin4 antibodies. A mixture of different in vitro synthesized 32P-labeled RNAs were injected into the cytoplasm of oocytes. 3 h later, immunoprecipitations were carried out with either anti-Gemin4 (22C10) or anti-Gemin2 (2E17) or control antibodies (SP2/O). Immunoprecipitated RNA (IP) was analyzed by gel electrophoresis. In the supernatant (SUP) panel 2.5% of each immunoprecipitation is shown. (B) Anti-Gemin4 antibodies can immunoprecipitate U1 and U5 snRNAs only from the cytoplasm. The indicated 32P-labeled RNAs were injected as a mixture into the cytoplasm of oocytes. After incubation for 18 h, the oocytes were dissected into nuclear (N) and cytoplasmic (C) fractions, and RNAs from both fractions were immunoprecipitated (IP) with either anti-Gemin4 (22C10), anti-Sm (Y12), or control antibodies (SP2/O). 2.5% of the input is shown.
Figure 8. A schematic representation of the SMN complexes. (A) The monomeric SMNÎEx7, associates with Gemin2 to form a dimeric complex. SMNÎEx7 lacks the ability to self-associate as well as to interact with Gemin3 and the Sm proteins (Lorson et al. 1998; Charroux et al. 1999; Pellizzoni et al. 1999). This monomeric SMNÎEx7âGemin2 complex is very likely an inactive complex (see text for more details). (B) Monomeric SMN, associated with Gemin2 which binds to SMN but not itself (Liu et al. 1997; data not shown), contains a low affinity binding site for the Sm proteins (Pellizzoni et al. 1999). Gemin3 associates with Gemin4 (this work). SMN self-associates, forming at least a SMNâGemin2 dimeric complex (Pellizzoni et al. 1999). Gemin3âGemin4 complex associates with SMNâGemin2 dimeric complex via an SMNâGemin3 interaction (Charroux et al. 1999). In this oligomeric conformation, a binding site with a much higher affinity for the Sm proteins is formed. The oligomeric form likely represents the active form of the SMN complex (see text for more details). (C) Gemin4 interacts with Gemin3* to form a dimeric complex that lacks SMN and Gemin2 (see text for details). Gemin3* represents the faster migrating form of Gemin3 observed in Fig. 4 B. Only one Sm snRNP protein is included in the drawing to simplify the model.
Andrade,
Human autoantibody to a novel protein of the nuclear coiled body: immunological characterization and cDNA cloning of p80-coilin.
1991, Pubmed
Andrade,
Human autoantibody to a novel protein of the nuclear coiled body: immunological characterization and cDNA cloning of p80-coilin.
1991,
Pubmed
Brzustowicz,
Genetic mapping of chronic childhood-onset spinal muscular atrophy to chromosome 5q11.2-13.3.
1990,
Pubmed
Burghes,
When is a deletion not a deletion? When it is converted.
1997,
Pubmed
Carvalho,
The spinal muscular atrophy disease gene product, SMN: A link between snRNP biogenesis and the Cajal (coiled) body.
1999,
Pubmed
Charroux,
Gemin3: A novel DEAD box protein that interacts with SMN, the spinal muscular atrophy gene product, and is a component of gems.
1999,
Pubmed
Choi,
Monoclonal antibody characterization of the C proteins of heterogeneous nuclear ribonucleoprotein complexes in vertebrate cells.
1984,
Pubmed
Coovert,
The survival motor neuron protein in spinal muscular atrophy.
1997,
Pubmed
Fischer,
The SMN-SIP1 complex has an essential role in spliceosomal snRNP biogenesis.
1997,
Pubmed
,
Xenbase
Fischer,
An essential signaling role for the m3G cap in the transport of U1 snRNP to the nucleus.
1990,
Pubmed
,
Xenbase
Francis,
Heterogeneity of subcellular localization and electrophoretic mobility of survival motor neuron (SMN) protein in mammalian neural cells and tissues.
1998,
Pubmed
Gall,
Is the sphere organelle/coiled body a universal nuclear component?
1995,
Pubmed
,
Xenbase
Gavrilov,
Differential SMN2 expression associated with SMA severity.
1998,
Pubmed
Gennarelli,
Survival motor neuron gene transcript analysis in muscles from spinal muscular atrophy patients.
1995,
Pubmed
Lamond,
Structure and function in the nucleus.
1998,
Pubmed
Lefebvre,
Identification and characterization of a spinal muscular atrophy-determining gene.
1995,
Pubmed
Lefebvre,
Correlation between severity and SMN protein level in spinal muscular atrophy.
1997,
Pubmed
Lerner,
Antibodies to small nuclear RNAs complexed with proteins are produced by patients with systemic lupus erythematosus.
1979,
Pubmed
Lerner,
Monoclonal antibodies to nucleic acid-containing cellular constituents: probes for molecular biology and autoimmune disease.
1981,
Pubmed
,
Xenbase
Liu,
A novel nuclear structure containing the survival of motor neurons protein.
1996,
Pubmed
,
Xenbase
Liu,
The spinal muscular atrophy disease gene product, SMN, and its associated protein SIP1 are in a complex with spliceosomal snRNP proteins.
1997,
Pubmed
Lorson,
SMN oligomerization defect correlates with spinal muscular atrophy severity.
1998,
Pubmed
Lorson,
A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy.
1999,
Pubmed
Lührmann,
Structure of spliceosomal snRNPs and their role in pre-mRNA splicing.
1990,
Pubmed
Matera,
Nuclear bodies: multifaceted subdomains of the interchromatin space.
1999,
Pubmed
Matera,
Coiled bodies and gems: Janus or gemini?
1998,
Pubmed
Mattaj,
Nuclear segregation of U2 snRNA requires binding of specific snRNP proteins.
1985,
Pubmed
,
Xenbase
Mattaj,
Cap trimethylation of U snRNA is cytoplasmic and dependent on U snRNP protein binding.
1986,
Pubmed
,
Xenbase
Maxwell,
The small nucleolar RNAs.
1995,
Pubmed
Melki,
De novo and inherited deletions of the 5q13 region in spinal muscular atrophies.
1994,
Pubmed
Melki,
Gene for chronic proximal spinal muscular atrophies maps to chromosome 5q.
1990,
Pubmed
Melki,
Molecular basis of spinal muscular atrophy: recent advances.
1999,
Pubmed
Neuman de Vegvar,
Nucleocytoplasmic transport and processing of small nuclear RNA precursors.
1990,
Pubmed
,
Xenbase
Ochs,
Detection of fibrillarin in nucleolar remnants and the nucleolar matrix.
1991,
Pubmed
,
Xenbase
Pearn,
Classification of spinal muscular atrophies.
1980,
Pubmed
Pellizzoni,
A novel function for SMN, the spinal muscular atrophy disease gene product, in pre-mRNA splicing.
1998,
Pubmed
Pellizzoni,
SMN mutants of spinal muscular atrophy patients are defective in binding to snRNP proteins.
1999,
Pubmed
Piñol-Roma,
Immunopurification of heterogeneous nuclear ribonucleoprotein particles reveals an assortment of RNA-binding proteins.
1988,
Pubmed
Raska,
Association between the nucleolus and the coiled body.
1990,
Pubmed
Reimer,
Human autoantibodies: probes for nucleolus structure and function.
1987,
Pubmed
Shevchenko,
Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels.
1996,
Pubmed
Singer,
Compartmentalization of eukaryotic gene expression: causes and effects.
1997,
Pubmed
Sleeman,
Newly assembled snRNPs associate with coiled bodies before speckles, suggesting a nuclear snRNP maturation pathway.
1999,
Pubmed
Smith,
Sno storm in the nucleolus: new roles for myriad small RNPs.
1997,
Pubmed
Tyc,
U3, U8 and U13 comprise a new class of mammalian snRNPs localized in the cell nucleolus.
1989,
Pubmed
Wilm,
Femtomole sequencing of proteins from polyacrylamide gels by nano-electrospray mass spectrometry.
1996,
Pubmed
Zieve,
Cell biology of the snRNP particles.
1990,
Pubmed